On Friday, Twist Bioscience Corp (NASDAQ: TWST) was -3.70% drop from the session before settling in for the closing price of $44.90. A 52-week range for TWST has been $14.42 – $60.90.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 60.13% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 4.32%. With a float of $56.07 million, this company’s outstanding shares have now reached $57.56 million.
In an organization with 919 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 40.53%, operating margin of -64.35%, and the pretax margin is -74.48%.
Twist Bioscience Corp (TWST) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Twist Bioscience Corp stocks. The insider ownership of Twist Bioscience Corp is 4.30%, while institutional ownership is 106.35%. The most recent insider transaction that took place on Aug 23 ’24, was worth 35,074. In this transaction Chief Accounting Officer of this company sold 813 shares at a rate of $43.14, taking the stock ownership to the 38,964 shares. Before that another transaction happened on Aug 23 ’24, when Company’s Officer proposed sale 813 for $43.14, making the entire transaction worth $35,075.
Twist Bioscience Corp (TWST) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 4.32% per share during the next fiscal year.
Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators
You can see what Twist Bioscience Corp (TWST) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.52. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.81, a number that is poised to hit -0.70 in the next quarter and is forecasted to reach -2.39 in one year’s time.
Technical Analysis of Twist Bioscience Corp (TWST)
Let’s dig in a bit further. During the last 5-days, its volume was 0.68 million. That was inferior than the volume of 1.02 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 47.71%. Additionally, its Average True Range was 2.74.
During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 47.27%, which indicates a significant increase from 26.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.60% in the past 14 days, which was lower than the 78.18% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $49.07, while its 200-day Moving Average is $39.27. However, in the short run, Twist Bioscience Corp’s stock first resistance to watch stands at $45.04. Second resistance stands at $46.84. The third major resistance level sits at $48.09. If the price goes on to break the first support level at $41.99, it is likely to go to the next support level at $40.74. Assuming the price breaks the second support level, the third support level stands at $38.94.
Twist Bioscience Corp (NASDAQ: TWST) Key Stats
There are 58,226K outstanding shares of the company, which has a market capitalization of 2.53 billion. As of now, sales total 245,110 K while income totals -204,620 K. Its latest quarter income was 81,460 K while its last quarter net income were -85,570 K.
